ADVERTISEMENT
ADVERTISEMENT
Cleveland Clinic Beats Interpreter s Religious Bias Suit
Law360 (March 12, 2021, 6:16 PM EST) A part-time Arabic interpreter s claims that he was passed up for a permanent job at the Cleveland Clinic because of his religion and lost work when he complained lacked enough evidence to sustain his suit against the medical center, an Ohio federal court has found.
U.S. District Judge Christopher Boyko on Thursday granted summary judgment to the Cleveland Clinic Foundation in Osama Makar s religious discrimination and retaliation case, calling Makar s evidence for his claims the very definition of hearsay.
Makar, a Coptic Christian, had argued that the Cleveland Clinic passed him over for a full-time interpreting position in favor.
Last week, Senator Tillis latest literary foray took the form of a letter to the Hon. Drew Hirschfeld, current Commissioner of Patents and Acting Director of the U.S. Patent and Trademark Office. In it, the Senator asks the USPTO to publish a request for information on the current state of patent eligibility jurisprudence in the United States, evaluate the responses, and provide us with a detailed summary of your finding, particularly with regard to how the current jurisprudence has adversely impacted investment and innovation in critical technologies like quantum computing, artificial intelligence, precision medicine, diagnostic methods, and pharmaceutical treatments. The letter illustrates and justifies the request by reciting the lack of consistency and clarity in our nation s patent eligibility laws. These circumstances have had a dramatic negative impact on investment, research, and innovation, not only discouraged investment in critical emerging technologies, but
Cleveland Clinic receives $15.5 million donation from Charles L. Shor Foundation
Charles L. Shor
Cleveland Clinic has received $15.5 million from the Charles L. Shor Foundation for its future Neurological Institute building and epilepsy research, according to a news release.
Of that, $10 million is earmarked for the new building, and $5.5 million will support an epilepsy study exploring the link between stress and seizures. In honor of the donation, the Clinic will name its epilepsy center The Charles Shor Epilepsy Center.
The news was announced as part of a virtual event marking the Clinic s Founders Day on Friday, Feb. 26 exactly 100 years after the opening ceremony of the Cleveland Clinic Foundation.
February 26, 2021
Giving potent antiplatelets up front to ACS patients, regardless of whether they may require CABG, could provide a survival benefit through early induction of platelet quiescence, according to results of a meta-analysis.
Senior study author Derek So, MD (University of Ottawa Heart Institute, Ontario, Canada), said the results build on data from the PLATO and TRITON-TIMI 38 trials, both of which suggested potent antiplatelets could bolster survival. Analysis of those two studies plus eight others found greater mortality overall when patients who were admitted for ACS and then underwent CABG had been given weaker antiplatelet strategies, such as aspirin alone or aspirin and clopidogrel, versus potent strategies like aspirin and P2Y12 inhibitors (OR 1.38; 95% CI 1.03-1.85).
E-Mail
IMAGE: HHMI announces the selection of 21 exceptional early career scientists as 2020 Hanna Gray Fellows to support diversity in biomedical research. The 2022 Hanna H. Gray Fellows Program competition will. view more
Credit: HHMI
Twenty-one outstanding scientists. Eight years of financial support. One tight-knit community.
Today, the Howard Hughes Medical Institute (HHMI) announced the selection of the 2020 Hanna Gray Fellows, a cohort of 21 early career researchers who are taking on some of the biggest challenges in the life sciences, such as understanding the innerworkings of the brain or the complexities of the immune system. By unlocking basic principles, their work could one day ease symptoms in patients with chronic pain, treat kids suffering from pediatric leukemia, and spark new therapeutics for emerging infectious diseases.